Cargando…
Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells
C17orf37/MGC14832, a novel gene located on human chromosome 17q12 in the ErbB-2 amplicon, is abundantly expressed in breast cancer. C17orf37 expression has been reported to positively correlate with grade and stage of cancer progression; however the functional significance of C17orf37 overexpression...
Autores principales: | Dasgupta, S, Wasson, L M, Rauniyar, N, Prokai, L, Borejdo, J, Vishwanatha, J K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726905/ https://www.ncbi.nlm.nih.gov/pubmed/19503095 http://dx.doi.org/10.1038/onc.2009.145 |
Ejemplares similares
-
HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer
por: Benusiglio, P R, et al.
Publicado: (2006) -
Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.
por: Swift, A., et al.
Publicado: (1995) -
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
por: Liu, Yunhua, et al.
Publicado: (2018) -
Retina-Targeted Delivery of 17β-Estradiol by the Topically Applied DHED Prodrug
por: Prokai-Tatrai, Katalin, et al.
Publicado: (2020) -
MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1
por: Rajendiran, Smrithi, et al.
Publicado: (2014)